Author: de Brito, M; Stevens, B R; Yiu, Z Z N
Title: Can artificial intelligence be used for accurate remote scoring of the Psoriasis Area and Severity Index in adult patients with plaque psoriasis? Cord-id: 2k6rcafj Document date: 2021_1_1
ID: 2k6rcafj
Snippet: A 47-year-old man with chronic plaque psoriasis and type II diabetes mellitus on ustekinumab 45mg 12 weekly injections, his first biologic therapy, was switched to adalimumab 40mg alternate weeks (10/02/2020) when his Psoriasis Area and Severity Index (PASI) was 11.4 due to loss of effectiveness. Due to the COVID-19 outbreak, the U.K Prime Minister advised clinically vulnerable people, including people on immunosuppressive medication with comorbidities including diabetes, to stay home avoiding f
Document: A 47-year-old man with chronic plaque psoriasis and type II diabetes mellitus on ustekinumab 45mg 12 weekly injections, his first biologic therapy, was switched to adalimumab 40mg alternate weeks (10/02/2020) when his Psoriasis Area and Severity Index (PASI) was 11.4 due to loss of effectiveness. Due to the COVID-19 outbreak, the U.K Prime Minister advised clinically vulnerable people, including people on immunosuppressive medication with comorbidities including diabetes, to stay home avoiding face-to-face contact (23/03/2020). We performed a Critically Appraised Topic review to understand whether it was possible to remotely assess his response to adalimumab with AI assistance.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date